Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Uprosertib
Trade Name
Synonyms GSK2141795|GSK-2141795|GSK 2141795
Drug Descriptions

Uprosertib (GSK2141795) is an ATP-competitive inhibitor of AKT, which leads to inhibition of PI3K/AKT signaling potentially resulting in inhibition of cell proliferation and anti-tumor growth (PMID: 24978597, PMID: 32062691).

DrugClasses Akt Inhibitor (Pan) 18 AKT Inhibitor (Pan) - ATP competitive 7

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cisplatin + Uprosertib Cisplatin Uprosertib 1 0
Dabrafenib + Trametinib + Uprosertib Dabrafenib Trametinib Uprosertib 0 0
Dabrafenib + Uprosertib Dabrafenib Uprosertib 0 1
Tipifarnib + Uprosertib Tipifarnib Uprosertib 1 0
Trametinib + Uprosertib Trametinib Uprosertib 2 8
Uprosertib Uprosertib 6 0


Additional content available in CKB BOOST